TVRD

Tvardi Therapeutics, Inc. Common Stock

164 hedge funds and large institutions have $324M invested in Tvardi Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 70 increasing their positions, 44 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-14
Holders Change %
-7.87%
% of All Funds
2.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
70
Reduced
44
Closed
26
Calls
$1.89M
Puts
$1.01M
Net Calls
+$879K
Net Calls Change
-$2.01M
Name Holding Trade Value Shares
Change
Shares
Change %
BlackRock
1
BlackRock
New York
$71M +$2.15M +6,375 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$31M +$376K +1,117 +1%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$24.8M
FCM
4
Farallon Capital Management
California
$23.4M
State Street
5
State Street
Massachusetts
$17.6M -$712K -2,114 -4%
DGI
6
Disciplined Growth Investors
Minnesota
$15.9M +$13.1K +39 +0.1%
KCM
7
Kingdon Capital Management
New York
$12.5M +$1.4M +4,167 +13%
C
8
Chescapmanager
Maryland
$10.9M
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$9.5M -$277K -821 -3%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$7.68M +$18.2K +54 +0.2%
Northern Trust
11
Northern Trust
Illinois
$6.79M +$547K +1,622 +9%
PA
12
Pinnacle Associates
New York
$6.6M -$349K -1,037 -5%
CWG
13
C WorldWide Group
Denmark
$5.46M
ClearBridge Investments
14
ClearBridge Investments
New York
$4.09M +$4.09M +12,134 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$4.04M +$315K +936 +8%
Morgan Stanley
16
Morgan Stanley
New York
$4.02M +$1.32M +3,925 +49%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$3.27M -$91.3K -271 -3%
Charles Schwab
18
Charles Schwab
California
$3.05M +$210K +623 +7%
Principal Financial Group
19
Principal Financial Group
Iowa
$2.75M -$10.4K -31 -0.4%
Invesco
20
Invesco
Georgia
$2.56M +$132K +392 +5%
RCMNY
21
Rubric Capital Management (New York)
New York
$2.5M
Goldman Sachs
22
Goldman Sachs
New York
$2.49M +$1.13M +3,345 +83%
RA
23
Royce & Associates
New York
$2.01M +$1.06M +3,156 +113%
JAM
24
Jupiter Asset Management
United Kingdom
$1.89M
ACM
25
Altium Capital Management
New York
$1.81M -$1.5M -4,450 -45%